TUTTLE: Comprehensive Care in patients with Diabetes and CKD from @goKDIGO #Nephpearls
TUTTLE: Lifestyle interventions in patients with Diabetes and CKD from @goKDIGO #Nephpearls
TUTTLE: Clinical trials of new drugs in patients with Diabetes and CKD from @goKDIGO #Nephpearls
CREDENCE: Canagliflozin reduces the risk of kidney failure or death due to CV or kidney disease by 30% compared to current standard of care ca. 2019 from @NEJM
#VisualAbstract by @brendonneuen
#Nephpearls
👉🏼 nejm.org/doi/full/10.10…
GLP-1 Receptor Agonists #Nephpearls
Benefits and harms of SGLT2 inhibitors, GLP-1 Receptor Agonists and DPP-4 I inhibitors #Nephpearls
Antihyperglycemic therapies in patients with Diabetes and CKD from @goKDIGO #Nephpearls
ROSSING: Dosing of Metformin in patients with Diabetes and CKD from @goKDIGO #Nephpearls
ROSSING: Glycemic monitoring and targets 🎯 in patients with Diabetes and CKD from @goKDIGO #Nephpearls
Glucose lowering medications in Type 2 Diabetes ca. 2019 #Nephpearls
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.